Cancel
David B. Klein
Chief Executive Officer
@
Click Therapeutics
About David B. Klein
David B. Klein is the Chief Executive Officer and co-founder of Click Therapeutics, known for conceiving the term 'Digital Therapeutics' and having over 18 years of experience in the life science industry.
Known information
David B. Klein serves as the Chief Executive Officer and co-founder of Click Therapeutics, a company he helped establish in 2012. He is credited with coining the term ‘Digital Therapeutics’ to describe the emerging industry focused on leveraging digital technologies to improve patient outcomes. Klein has over 18 years of experience in the life science industry, during which he has played key roles in founding, financing, and operating numerous life science companies. In 2019, Goldman Sachs recognized him as one of the 100 Most Intriguing Entrepreneurs. He has also presented at the 42nd Annual J.P. Morgan Healthcare Conference. Klein is a strong advocate for the rigorous clinical validation and regulatory review of digital therapeutics.
About Click Therapeutics
Click Therapeutics develops and commercializes software as prescription medical treatments, focusing on cognitive and neurobehavioral mechanisms to address unmet medical needs. Headquartered in New York, the company collaborates with major healthcare firms and has received significant funding and recognition for its innovative digital therapeutics.
Report inaccurate information
